How to Avoid the Side Effects of GLP-1s When You Have Type 2 Diabetes

How to Avoid GLP-1 Side Effects if You Have Type 2 Diabetes

How to Avoid GLP-1 Side Effects if You Have Type 2 Diabetes
iStock

GLP-1 receptor agonists, such as semaglutide, and dual agonists, like tirzepatide, have become powerful tools for managing type 2 diabetes. But, like any medication, they can come with side effects.

From nausea and constipation to fatigue and accelerated facial aging, these reactions can range from mildly inconvenient to completely intolerable. The good news? Most people can manage, minimize, or even sidestep these side effects completely with the right preparation and a few tweaks to treatment.

Common Side Effects of GLP-1s

Side effects are a common complaint for people taking GLP-1s. In fact, research shows that the side effects cause some people to stop taking the medication altogether.

“The majority of people will experience some degree of gastrointestinal issues with a GLP-1, especially as we start the medication and increase the dose,” says Shiara Ortiz-Pujols, MD, MPH, a weight management physician at Northwell Health Physician Partners Surgery in Staten Island, New York.

However, while roughly 50 to 60 percent of people can experience gastrointestinal distress at the outset, this number decreases over time, according to research.

Many of the side effects listed below can happen to anyone, but some people — such as those with underlying gastric motility disorders or gastroparesis — can be more at risk for them than others, says Kristin Criner, MD, an endocrinologist and associate professor of clinical medicine at the Lewis Katz School of Medicine at Temple University in Philadelphia.

If you’re starting a GLP-1, here’s how to recognize (and hopefully minimize) the most common side effects.

Nausea and Vomiting

As many as 50 percent of people on a GLP-1 will have some nausea after starting the medication. This is especially true in the first 4 to 5 weeks, when gastric emptying (the rate that food moves through the stomach) slows.

Nausea typically occurs within 24 to 48 hours, says Dr. Ortiz-Pujols. Usually, it’s mild, but severe nausea and vomiting can lead to dehydration or — rarely — acute kidney injury or gastrointestinal obstruction, says Dr. Criner.

To keep nausea to a minimum, try to eat at least 30 minutes after the GLP-1 dose, and stick to foods such as apples, crackers, and mint- or ginger-based foods and drinks. You may also want to avoid drinking during meals themselves. Instead, drink at least 30 minutes before or after eating.

You may also notice that certain foods are more likely to trigger nausea than others. Some common offenders include greasy, high-fat, processed, and spicy foods, as well as alcohol and carbonated beverages, says Ortiz-Pujols. If that’s the case, you may want to limit them in your diet. A nutritionist can help you determine which foods to avoid.

Constipation and Diarrhea

Both slowness in the gut and an urgent need to go are common side effects, says Ortiz-Pujols. “Initially, you might feel that your bowel movements are slowing down in frequency. And as we go up in dose, that often becomes more pronounced,” she says.

Once it worsens, it can become so uncomfortable that some people feel the need to go to the emergency room. If constipation is a constant problem, talk to your doctor about whether you should take a stool softener.

Sometimes, constipation can also shift to urgent diarrhea, says Ortiz-Pujols. If you get diarrhea, try limiting your intake of greasy and more processed foods, she says. You should also make sure you’re drinking plenty of fluids, which can help ward off both diarrhea and constipation.

Dehydration

Dehydration can be caused by diarrhea or nausea and vomiting, but you could also become dehydrated simply because you don’t feel like you need to drink as much as usual. “These medications reduce appetite not only for food, but some people experience a lower appetite for hydration as well,” says Ortiz-Pujols.

To make sure you’re staying hydrated, try drinking water with lemon or sipping on soups such as chicken broth.

Facial Aging

Stemming, in part, from a rapid loss of fat in the face, some people on a GLP-1 say their facial anatomy looks different, says Criner. Think: hollowed cheeks and temples, sagging skin along the jawline and neck, sunken or dark under-eye circles, and worsened wrinkles.

To sidestep this side effect, Criner recommends aiming for more-gradual weight loss, eating a protein-rich diet, and staying hydrated. If you still need help minimizing these facial effects, getting “cosmetic procedures like facial fillers, skin-tightening treatments, or surgical interventions can restore facial volume and manage excess skin,” she says.

Fatigue and Weakness

These feelings are common the first day or two after taking a dose, but some medications are bigger culprits than others, says Ortiz-Pujols. If you’re noticing debilitating fatigue or weakness, talk to your doctor about switching to a new medication, which may help relieve these side effects.

Hypoglycemia

Some people with type 2 diabetes can also develop low blood sugar — typically defined as below 55 milligrams per deciliter (mg/dL) or 3.1 millimoles per liter (mmol/L) — while taking a GLP-1, especially if they’re also on other medications, such as insulin, that can also lower blood sugar levels.

If you’re having frequent drops in blood sugar levels, talk to your doctor, who may recommend lowering the medication dosage. If you do feel hypoglycemic, eat foods with simple sugars, such as a banana, or drink a half cup of apple juice.

Teeth Problems

Because you’re likely eating — and possibly also drinking — less while on a GLP-1, your mouth produces less saliva than usual, says Oritz-Pujols. The resulting dry environment can lead to cavities and gum disease.

Along with drinking enough water, ask your doctor if you should chew sugar-free gum or use a mouthwash designed for dry mouth.

Tips to Reduce Side Effects

Criner advises her patients to increase their intake of dietary fiber, stay hydrated, and use stool softeners to prevent symptoms from worsening.

Ask your doctor what other steps you can take on your own to slash side effects. Things such as reducing meal size, eating only when hungry, and practicing mindfulness while eating, which includes stopping when you feel full, can all help ease gastrointestinal issues, says Criner.

Still, even if you’re doing everything you can to minimize side effects, you may not be able to tolerate that particular GLP-1 forever.

For instance, if you experience acute abdominal pain and are diagnosed with pancreatitis or gastrointestinal obstruction, you should stop taking the medication immediately and not restart it, says Criner. (Physicians will likely stop prescribing a GLP-1 or dual agonist if you receive a pancreatitis diagnosis.) Your doctor should also reevaluate treatment and dosage if you have any other severe side effects.

“More often than not, patients may need to try lower doses of the medication or an alternative class of GLP-1 agonists, as there is a variation in tolerability profile between them,” says Criner.

Ortiz-Pujols agrees, noting that finding the right medication and dosage is likely just a matter of trial and error.

The Takeaway

  • GLP-1 medications are highly effective for managing type 2 diabetes, but they often come with uncomfortable side effects. Although common, they don’t have to totally derail treatment.
  • Adjusting your diet, gradually increasing the medication dose, and staying hydrated can all help ward off uncomfortable side effects.
  • Always tell your doctor about how you’re tolerating the medication. Your doctor can help you troubleshoot symptoms and come up with a treatment plan, so you can reap all the benefits, while keeping side effects to a minimum.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Do D et al. GLP-1 Receptor Agonist Discontinuation Among Patients With Obesity and/or Type 2 Diabetes. JAMA Network Open. May 2024.
  2. Drucker DJ. Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity. Diabetes Care. November 2024.
  3. Gorgojo-Martínez JJ et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with GLP-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of Clinical Medicine. January 2023.
  4. Hypoglycemia (Low Blood Sugar). Cleveland Clinic. January 31, 2023.
  5. Dry Mouth Treatment: Tips for Controlling Dry Mouth. Mayo Clinic. May 27, 2023.
Stephanie-Young-Moss-bio

Stephanie Young Moss, PharmD

Medical Reviewer

Stephanie Young Moss, PharmD, has worked in pharmacy, community outreach, regulatory compliance, managed care, and health economics and outcomes research. Dr. Young Moss is the owner of Integrative Pharmacy Outcomes and Consulting, which focuses on educating underserved communities on ways to reduce and prevent health disparities. She uses her platform to educate families on ways to decrease and eliminate health disparities by incorporating wellness and mental health techniques.

Young Moss is the creator of the websites DrStephanieYoMo.com and MenopauseInColor.com, providing practical health and wellness tips and resources for women experiencing perimenopause and menopause. She has over 100,000 people in her social media communities. She has also contributed to Pharmacy Times and shared her views on international and national podcasts and local television news.

She has served on various boards for organizations that focus on health equity, decreasing implicit bias, addressing social determinants of health, and empowering communities to advocate for their health. She has also been on the boards for the Minority Health Coalition of Marion County and Eskenazi Health Center, for which she was the clinical quality committee chair and board secretary and is currently the board treasurer. She is a board member for Community Action of Greater Indianapolis.

Laurel Leicht

Laurel Leicht

Author

Laurel Leicht has been a writer and editor for nearly two decades. A graduate of the College of William and Mary and the master's program at the Missouri School of Journalism, she covers a wide range of health and fitness topics, including breast cancer, various chronic conditions, mental health, and cardiovascular health.